Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SMS Pharmaceuticals Ltd Call Transcript 2024

Nov 13, 2024

62302_rns_2024-11-13_ef29bd89-ef78-47b9-a816-1b725f8228ee.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [241 x 158] intentionally omitted <==

Date: 13[th] November, 2024

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the quarter ended 30[th] September, 2024.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and further to our letter dated 07[th ] November, 2024 regarding intimation of Investors/ Analyst conference call, held on today i.e., 13[th] November, 2024, on the Unaudited Financial Results of the Company for the quarter and half year ended 30[th] September, 2024, we would like to inform you that the audio recording of the said call made available on the Company’s website. This can be accessed via the following link.

https://smspharma.com/financials/audio-or-video-recording-of-investors-meet/

You are requested to take the same on record.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMALE Digitally signed by THIRUMALESH TUMMA SH TUMMA Date: 2024.11.13 17:16:44 +05'30' Thirumalesh Tumma Company Secretary